Veterinarni Medicina最新文献

This experimental study evaluated the therapeutic potential of a liquorice-derived hydroalcoholic extract in managing experimentally induced peritonitis in New Zealand rabbits. The animals were randomly divided into six groups (n = 6): one control group, one negative control group (infected but untreated), three treatment groups that received the liquorice-derived extract at 0.5, 1, and 2 g/kg, and one positive control group treated with enrofloxacin. The confirmation of peritoneal infection relied on histopathological and radiographic tests. The effect of the liquorice extract on the peritoneal infection was evaluated using biochemical, haematological, and ultrasound analyses across the groups. The ultrasound examination, along with the haematological and biochemical evaluation on the 20^th day after induction, showed significant differences between the groups. The results demonstrated that higher doses of 1 g/kg and 2 g/kg were more effective than the lower dose of 0.5 g/kg. The haematological and biochemical analyses revealed significant differences in several variables (including WBC, neutrophils, fibrinogen, and liver enzymes) between the treated and control groups, with the most pronounced improvements observed in the group receiving 2 g/kg of liquorice extract, suggesting a dose-dependent therapeutic effect. The administration of a hydroalcoholic extract of liquorice at different doses, along with the standard treatment with enrofloxacin, affected various haematological and biochemical variables in the context of peritoneal infection management. In conclusion, the effectiveness of the liquorice-derived extract is dose-dependent and could be used as an effective therapeutic agent in peritoneal infections in New Zealand rabbits. These findings showed that the liquorice-derived extract effectively improves the local inflammatory and structural changes associated with peritoneal infection without adversely affecting systemic biochemical homeostasis.

This study aimed to evaluate the effectiveness of mannan-oligosaccharides (MOSs) in broiler chicken feed throughout the complete rearing cycle, focusing on zootechnical performance and lactic acid bacteria. Over a period of 49 days, a total of one thousand and eighty (1 080) day-old ISA 15 chicks were divided into two (control and experimental) groups of 540 subjects each (9 replicates of 60 chicks per treatment). They were fed the same basic diet, but only the experimental group received a yeast cell wall extract-based prebiotic (AGRIMOS^®, France), administered continuously at a dose of 2 g/kg throughout the different rearing phases. Under our local conditions, the prebiotic supplementation resulted in a significant increase in body weight gain (P < 0.01), reaching 1 559.82 ± 41.47 g during the growth phase and 913.20 ± 72.58 g during the finishing phase. Moreover, a significant reduction in the feed conversion ratio was observed throughout the rearing cycle (P < 0.05). Across all segments of the analysed intestinal tract (duodenum, ileum, and caecum), the data showed that chickens supplemented with the prebiotic had a significantly higher number of lactic acid bacteria than the control group at the start, growth, and finishing phases (P < 0.01). Our findings demonstrated a clear impact of the prebiotic on the feed utilisation under our rearing conditions, which required further studies to elucidate the underlying mechanisms of action.

Cerebellar hypoplasia caused by feline panleukopenia virus (FPV) is well documented in domestic cats. Still, it remains unreported in wild felid species, including the Amur leopard cat (Prionailurus bengalensis euptilura). Understanding the impact of such viral diseases on wild populations is crucial for advancing conservation efforts and protecting wildlife. An orphaned Amur leopard cat exhibiting idiopathic ataxia was rescued. Initial diagnostics, including physical examination, radiography, and blood analysis, yielded no remarkable findings, though its clinical signs indicated an underlying neurological problem. Subsequent real-time polymerase chain reaction tests detected FPV. Magnetic resonance imaging (MRI) revealed brain lesions, including reduced cerebellar parenchyma and cerebrospinal fluid occupying the space where the cerebellum should be located. These findings suggested cerebellar hypoplasia caused by in utero FPV infection. The Amur leopard cat was euthanised owing to its permanent disability, and the necropsy confirmed a markedly shrunken cerebellum. At the same time, histopathology identified decreased cellularity of the molecular and granular layers of the cerebellar cortex. These results coincided with the MRI findings. This report suggests that cerebellar hypoplasia caused by FPV can occur in wild felid species.

Medetomidine, an alpha-2 adrenoreceptor agonist, is used for sedation. This study aimed to determine the influence of the alpha-2 adrenoreceptor antagonist vatinoxan, co-administered with medetomidine, on healthy dogs' intraocular pressure (IOP) and pupil diameter (PD). A prospective, randomised, masked clinical study was performed. A total of 40 conscious dogs were allocated to one of two groups: medetomidine 0.01 mg/kg with vatinoxan 0.2 mg/kg intravenously (MV-group, n = 20) or medetomidine 0.01 mg/kg intravenously (M-group, n = 20). The IOP, PD, heart rate, and mean arterial pressure were measured prior to baseline and 5, 10, and 20 min after drug administration. Data were analysed using one- and two-way repeated measures ANOVA or their non-parametric equivalents (P < 0.05). No significant differences in IOP within or between groups were recorded. In the MV-group, PD remained unchanged compared to baseline. In the M-group, PD significantly (P = 0.007, P < 0.001, P < 0.001) decreased compared to baseline at all observation times. PD was significantly (P = 0.010, P < 0.001, P < 0.001) smaller in the M-group at all observation times compared to the MV-group. Vatinoxan co-administered with medetomidine, as well as medetomidine alone, did not significantly influence IOP. Vatinoxan with medetomidine did not affect PD, while medetomidine alone significantly reduced it.

This study aimed to determine coagulation changes in bitches with pyometra based on a series of coagulation tests and thromboelastography (TEG), and to assess the incidence of disseminated intravascular coagulation (DIC). Eighteen bitches with pyometra and thirty-four control bitches were examined. Haematological, biochemical, and following haemostasis parameters were measured, including: prothrombin time (PT), activated partial thromboplastin time (aPTT), antithrombin activity (AT), and levels of fibrinogen (FBG), d-dimers (DD), tissue factor (TF), plasminogen (PLG), tissue plasminogen activator inhibitor 1 (TPAI-1), and thromboelastography. DIC was considered present if three or more of these parameters were abnormal: platelet count (<153 × 10⁹/l), PT (>8.1 s), aPTT (>25.5 s), FBG (<0.6 g/l), DD (>0.2 mg/l), and AT (<107%). Significant differences were found in the PT, aPTT, FBG, DD, TPAI-1, clotting time, α-angle, and maximal amplitude. According to our scoring system, two patients were DIC positive. The study found alterations in several coagulation tests and hypercoagulable TEG tracings in bitches with pyometra, which point to excessive activation of coagulation, delayed fibrinolysis, and the presence of DIC. No patient bled abnormally, which may suggest that DIC is not overt in the majority of pyometra patients.

Coinfection of porcine circovirus type 2 (PCV2) with Mycoplasma hyopneumoniae (M. hyo) causes major worldwide economic losses within the swine industry. This study aimed to assess the safety and efficacy of a single dose of a bivalent vaccine containing PCV2d and M. hyo antigen (Cirbloc^® M Hyo) under field conditions. Two studies were performed under the GCP (Good Clinical Practice) requirements on farrow-to-finish farms in Hungary and Cyprus. On both farms, the presence of both PCV2 and M. hyo infection was demonstrated. For both studies, safety parameters were observed and measured from inclusion at 21 (±3) days of age until 14 days after vaccination. Efficacy parameters were observed and measured from inclusion until slaughter. Administration of the vaccine was safe in both studies, as no general, immediate, or local reactions were observed. The efficacy of the vaccine was confirmed in both studies as the following parameters were significantly reduced in the vaccinated groups compared to the control groups: viraemia, faecal shedding, viral load in lungs and in all collected lymphoid tissues, M. hyo-specific lung lesions, and average daily body weight gain. These results collectively support the vaccine's potential as an effective tool for disease control.

This study aimed to comprehensively evaluate the prevalence, severity, and risk factors associated with gastric lesions in fattening pigs across all four seasons in Slovakia. A total of 1 944 porcine stomachs were examined post-mortem at commercial slaughterhouses, focusing on the non-glandular region (pars oesophagea). A macroscopic evaluation was conducted using a standardised scoring system (0-3), in which gastric lesions, including parakeratosis, erosions, and ulcerations, were observed in 48% of the examined stomachs. Significant seasonal variation was detected, with the highest lesion prevalence recorded during the summer months, likely due to heat stress and reduced feed intake, and the lowest incidence of pathological changes seen in autumn. The gastric fullness had a notable impact: empty and liquid-filled stomachs were more frequently associated with severe mucosal damage, while full stomachs exhibited a protective effect. Furthermore, the feeding regimen played a crucial role: the pigs receiving wet feed had a significantly lower prevalence of gastric lesions than those on a dry feeding regimen. These results underscore the multifactorial nature of gastric ulceration in pigs and highlight the importance of nutritional and environmental management strategies in intensive production systems.

Pulmonary fibrosis is not only a consequence of the recent COVID-19 pandemic, but is increasingly recognised by both human and veterinary healthcare providers. Pulmonary fibrosis is a progressive condition that leads to a decline in respiratory function and even death. In this work, we compared MSC-derived exosomes with conventional anti-inflammatory drug treatments. Exosomes from stimulated MSCs displayed higher miRNA concentrations (in particular, miRNA-30b was significantly increased). A set of rats with induced lung fibrosis were divided into four groups: NC (control - no treatment), A2 (exosome infusion), A3 (exosome infusion combined with ultrasound stimulation), and F1 (tamoxifen/metformin drug treatment). The rats' lungs were subjected to histological analysis; the fibrosis scores for groups F1 and A3 were very similar and decreased significantly compared with group NC. Ultrasound-facilitated diffusion of exosomes from the capillaries into the lung tissue could represent an innovative therapeutic approach for slowing fibrosis and prolonging the active life of the organism.

This study examines the prevalence of helminthic infestations, risk factors, and odds ratios in 1 300 cattle, revealing significant patterns in parasite distribution and influencing factors. Overall, 60.3% of cattle were infested with one or more types of parasites, with Moniezia spp. being the most prevalent (46.9%), followed by Fasciola spp. (36.9%), Paramphistomum spp. (26.8%), and Avitellina spp. (10.8%). Among the seasons, winter exhibited the highest infestation rate (66.1%), and calves under one year of age were more commonly infested (64.2%) than older cattle (over three years: 51.1%, OR = 0.584 1). Distinct seasonal and age-related patterns were observed for specific parasites. Fasciola spp. was most prevalent in winter (45.09%) and among the youngest cattle (47.87%), while Paramphistomum spp. and Moniezia spp. showed less variation across seasons. Avitellina spp. had the lowest infestation rates in the spring, and cattle older than three years were affected. Co-infections were common, notably between Fasciola and other parasites, with the highest co-infestation rate observed between Avitellina spp. and Moniezia spp. Analysis of deworming efficacy indicated higher treatment success for Fasciola spp. and Paramphistomum spp., lower odds of response for Avitellina spp., and no significant treatment effect for Moniezia spp. Microscopic and pathological examinations were also conducted. These results demonstrate the necessity of thorough deworming procedures along with targeted parasite control to reduce significant health hazards in cattle populations.

This study was conducted to examine the effects of zinc oxide nanoparticles (ZnO NPs) on the malondialdehyde (MDA) concentrations, superoxidase dismutase (SOD), glutathione peroxidase (GPx) and caspase-3 (CASP3) activities, tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), immunoglobulin (Ig) E, G, M and zinc (Zn) concentrations in the serum/plasma and liver tissues of rats. Forty Wistar Albino rats were separated into five equal groups as the control, 5 and 10 mg/kg, b.w./day ZnO, 5 and 10 mg/kg b.w./day ZnO NPs were administered i.p. every other day for 14 days. The plasma MDA and plasma/liver TNF-α concentrations increased in the 10 mg/kg ZnO, 5 and 10 mg/kg ZnO NPs groups. The plasma SOD, CASP3, plasma/liver GPx activities and serum Zn concentrations increased in all the Zn groups. The highest SOD, GPx and CASP3 activities were detected in the 5 mg/kg ZnO NPs group. The plasma IgG concentrations increased, especially in the ZnO NPs groups. The study findings suggest that 5 mg/kg ZnO NPs could potentially have an ameliorative effect on the possible adverse effects of oxidative stress. These nanoparticles demonstrate their ability to combat oxidative stress by increasing the plasma/tissue SOD, GPx, and CASP3 activities, TNF-α, and IgG concentrations. However, the effectiveness of the nanoparticles may vary depending on the synthesis method, application time, and concentration.